REVIEWHereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
Section snippets
Overview of HHT
HHT, also known as Osler–Weber–Rendu syndrome,[1], [2], [3] is one of the most common disorders to be inherited as an autosomal dominant trait. Careful epidemiological studies reveal that it affects approximately 1 in 5000 individuals,[4], [5] with regional differences,6 and isolated communities displaying higher prevalences due to founder effects.[7], [8]
HHT was first described as a familial disease characterised by severe recurrent nasal and gastrointestinal bleeding with associated anaemia,
Histopathology
As in other telangiectatic states,89 the smallest HHT cutaneous telangiectatic lesion appears to be a focal dilatation of the post capillary venule in the upper horizontal plexus.90 Computer reconstruction of serial 1–2 mm sections suggest that the dilated post capillary venules enlarge, connect with dilated arterioles with loss of the intervening capillary bed, and form arteriovenous communications,90 associated with a lymphocytic perivascular cell infiltrate.90 Microscopic telangiectasia are
Management overview
Several helpful articles have been published in recent years guiding management practice. International HHT Guidelines published on line more than 12 months ago 32 were based on systematic assessments of the HHT publications up to October 2006. The 33 recommendations, representing the product of a fairly strenuous review process involving multiple experts, are a very helpful starting point for the field, and are presented in a separate column within Table 1.
The 2006–9 HHT evidence base
Clinical diagnosis
The mainstay of diagnosis remain the Curaçao Criteria, international consensus diagnostic criteria developed between 1997 and 1999 2 (Table 1), and recently validated.72 An individual has a diagnosis of “definite HHT” if three criteria are present; “suspected HHT” if two are present, and “unlikely HHT” if only one is present. A crucial issue for families and medical practitioners, is that no child of a patient with HHT can be informed they do not have HHT, unless they have been shown not to
AVMs
Details of the treatment of each type of AVM are beyond the scope of this text: the interested reader is referred to the references in Table 1, and recent treatment texts for general aspects of HHT [3], [32] and AVMs in cerebral,[68], [209], [210], [211] pulmonary,[57], [58], [59], [60], [61], [66], [105] hepatic[73], [74], [75], [76] and spinal[67], [68], [74], [75], [76] circulations.
Management of iron deficiency anaemia
In this chronic condition, it is essential to reserve treatments carrying higher risk, for patients with the
Perspective
For families with HHT, the recent advances in scientific and medical understanding of their condition are encouraging after the decades of limited advances. There are genuine hopes for improved and targeted treatment modalities, and emerging evidence that existing strategies are already offering affected individuals a better medical outlook than their grandparents.
Yet there are others for whom the deluge of new and frightening information holds concerns. As one attendee of the 2009 UK HHT
Conflict of interest statement
No conflicts of interest to declare.
Acknowledgments
The author thanks Dr. James Jackson, Dr. Alan Guttmacher and Dr. Fatima Govani for reviewing the manuscript; Katharine Thompson for bibliographical software assistance; and Professor John West for his framework of pulmonary circulatory concepts. She acknowledges support from the NIHR Biomedical Research Centre Funding Scheme, the British Heart Foundation, and British HHT families.
References (229)
- et al.
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia is associated with mutations in MADH4 (SMAD4)
Lancet
(2004) - et al.
Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement
Gastroenterology
(1999) - et al.
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers
J Thromb Haemost
(2007) - et al.
Genotype–phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network
Genet Med
(2007) - et al.
Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease) with tranexamic acid
Acta Otorrinolaringol Esp
(2007) - et al.
Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT
Chest
(2007) - et al.
Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations
J Vasc Interv Radiol
(2006) - et al.
Embolization of pulmonary arteriovenous malformations with amplatzer vascular plugs: safety and midterm effectiveness
J Vasc Interv Radiol
(2010) - et al.
Transjugular intrahepatic portosystemic shunt for variceal hemorrhage due to recurrent of hereditary hemorrhagic telangiectasia in a liver transplant
J Vasc Interv Radiol
(2010) - et al.
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT
Clin Neurol Neurosurg
(2008)
APSA Education Committee Review of radiation risks from computed tomography: essentials for the pediatric surgeon
J Pediatr Surg
Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia
J Invest Dermatol
Pulmonary telangiectasia: report of a case proven by pulmonary biopsy
J Thorac Surg
Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications
J Vasc Surg
Endoglin expression is reduced on normal vessels but still detectable in arteriovenous malformations of patients with hereditary haemorrhagic telangiectasia type I
Am J Pathol
Early adaptive responses of the vascular wall during venous arterialization in mice
Am J Pathol
Hereditary hemorrhagic telangiectasia
New Engl J Med
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome)
Am J Med Genet
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
Eur J Hum Genet
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients
J Intern Med
Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan
Hum Mut
An abnormal concentration of cases of Rendu–Osler disease in the Valserine valley of the French Jura: a geneological and demographic study
Ann Hum Biol
The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening
Am J Med Genet
Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients
Eur J Hum Genet
Pancreatic involvement in hereditary hemorrhagic telangiectasia: assessment with multidetector helical CT
Radiology
Clinical and molecular features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
New Engl J
High-output right ventricular failure secondary to hepatic arteriovenous microfistulae Selective arterial embolization treatment
Arch Intern Med
Unusual complications after embolization of a pulmonary arteriovenous malformation
Chest
Liver disease in patients with hereditary hemorrhagic telangiectasia
N Engl J Med
Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure
Eur Resp J
Elevated Factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism
Thromb Haemost
Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT
Curr Pharm Des
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
Nat Genet
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
Nat Genet
Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia
J Int Med
Genotype–phenotype relationship in hereditary haemorrhagic telangiectasia
J Med Genet
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype
Hum Mutat
Genotype–phenotype correlation in hereditary hemorrhagic telangiectasia
Am J Med Genet A
Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
J Clin Invest
Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice
Am J Physiol Lung Cell Mol Physiol
Pathogenesis of arteriovenous malformations in the absence of endoglin
Circ Res
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
Nat Med
International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia
J Med Genet
An epistaxis severity score for hereditary hemorrhagic telangiectasia
Laryngoscope
Primary determinants of ischaemic stroke/ brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia
Thorax
The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis
Am J Rhinol
Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary hemorrhagic telangiectasia epistaxis
Am J Rhinol
Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients
Am J Rhinol Allergy
Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis
Rhinology
Cited by (383)
Oral manifestations and dental considerations of patients with hereditary hemorrhagic telangiectasia: a scoping review
2023, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyFunctional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants >5 kb from coding DNA
2023, American Journal of Human GeneticsNovel vascular roles of human endoglin in pathophysiology
2023, Journal of Thrombosis and HaemostasisSoluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin
2023, Journal of Thrombosis and HaemostasisThe role of interventional radiology in treatment of patients with hereditary hemorrhagic telangiectasia
2023, European Journal of Radiology